Abstract
The majority of women treated today for breast cancer are long-term survivors. The overall benefits of adjuvant therapy in women with breast cancer favor treatment even in the subset of patients with node-negative invasive breast cancer. The short- and long-term side effects of combined modality treatment have a significant impact on morbidity and quality of life. Continued emphasis on improving survival, decreasing recurrence, and minimizing treatment toxicity are the goals of ongoing breast cancer research.
| Original language | English |
|---|---|
| Pages (from-to) | 211-222+238 |
| Journal | Clinical Advances in Hematology and Oncology |
| Volume | 3 |
| Issue number | 3 |
| State | Published - Mar 2005 |
| Externally published | Yes |
Keywords
- Adjuvant chemotherapy
- Breast cancer
- Hormonal therapy
- Short- and long-term side effects
- Survivorship